139 related articles for article (PubMed ID: 3296960)
1. [Clinical significance of serum DU-PAN-2 surveyed by solid-phase sandwich EIA for DU-PAN-2].
Ishii M; Urabe T; Seino Y
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1860-5. PubMed ID: 3296960
[TBL] [Abstract][Full Text] [Related]
2. [Determination of serum DU-PAN-2 by enzyme immunoassay in patients with various digestive cancers].
Takemori Y; Sawabu N; Satomura Y; Ohta H; Watanabe H; Okai T; Mai M; Hattori N; Akiyama T; Hashimoto T
Gan To Kagaku Ryoho; 1987 Jan; 14(1):119-26. PubMed ID: 3541791
[TBL] [Abstract][Full Text] [Related]
3. [Detection of DU-PAN-2 antigen (pancreatic cancer-associated antigen) in sera of patients with cancer of the digestive tract].
Takami H; Furuuchi T; Ogata Y; Abe O
Gan To Kagaku Ryoho; 1986 Oct; 13(11):3207-14. PubMed ID: 3777958
[TBL] [Abstract][Full Text] [Related]
4. [Clinical investigation of carbohydrate antigen CA-50].
Ishii M; Abe O; Okura H; Okazaki N; Kawai T; Saito Y; Sawabu N; Takamizawa Y; Takeuchi T; Niitani H
Gan To Kagaku Ryoho; 1987 Aug; 14(8):2548-55. PubMed ID: 3304170
[TBL] [Abstract][Full Text] [Related]
5. Correlative study on expression of CA 19-9 and DU-PAN-2 in tumor tissue and in serum of pancreatic cancer patients.
Takasaki H; Uchida E; Tempero MA; Burnett DA; Metzgar RS; Pour PM
Cancer Res; 1988 Mar; 48(6):1435-8. PubMed ID: 3162196
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic usefulness and limitation of measuring pancreatic cancer associate antigen, SPan-1, in patients with pancreatic cancer].
Satake K; Chung YS; Umeyama K; Takeuchi T; Kim YS
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1139-46. PubMed ID: 2730018
[TBL] [Abstract][Full Text] [Related]
7. Co-expression of CA 19-9, DU-PAN-2, CA 125, and TAG-72 in pancreatic adenocarcinoma.
Tempero M; Takasaki H; Uchida E; Takiyama Y; Colcher D; Metzgar RS; Pour PM
Am J Surg Pathol; 1989; 13 Suppl 1():89-95. PubMed ID: 2699170
[TBL] [Abstract][Full Text] [Related]
8. A pancreatic oncofetal antigen (POA): its characterization and application for enzyme immunoassay.
Oguchi H; Homma T; Kawa S; Nagata A; Furuta S; Fukui H
Cancer Detect Prev; 1984; 7(1):51-8. PubMed ID: 6367984
[TBL] [Abstract][Full Text] [Related]
9. A sandwich enzyme immunoassay of an adenocarcinoma-associated antigen, YH206, in cancer sera.
Hinoda Y; Imai K; Ban T; Endo T; Yachi A
Jpn J Cancer Res; 1987 Jun; 78(6):607-13. PubMed ID: 3038813
[TBL] [Abstract][Full Text] [Related]
10. Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies.
Metzgar RS; Gaillard MT; Levine SJ; Tuck FL; Bossen EH; Borowitz MJ
Cancer Res; 1982 Feb; 42(2):601-8. PubMed ID: 7034925
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies against human pancreatic adenocarcinoma: distribution of DU-PAN-2 antigen on glandular epithelia and adenocarcinomas.
Borowitz MJ; Tuck FL; Sindelar WF; Fernsten PD; Metzgar RS
J Natl Cancer Inst; 1984 May; 72(5):999-1005. PubMed ID: 6371347
[TBL] [Abstract][Full Text] [Related]
12. Lewis and secretor gene dosages affect CA19-9 and DU-PAN-2 serum levels in normal individuals and colorectal cancer patients.
Narimatsu H; Iwasaki H; Nakayama F; Ikehara Y; Kudo T; Nishihara S; Sugano K; Okura H; Fujita S; Hirohashi S
Cancer Res; 1998 Feb; 58(3):512-8. PubMed ID: 9458099
[TBL] [Abstract][Full Text] [Related]
13. Isolation and properties of a human pancreatic adenocarcinoma-associated antigen, DU-PAN-2.
Lan MS; Finn OJ; Fernsten PD; Metzgar RS
Cancer Res; 1985 Jan; 45(1):305-10. PubMed ID: 3965141
[TBL] [Abstract][Full Text] [Related]
14. [A basic and clinical study of CA 19-9-MP-Mitsui kit for determination of CA 19-9].
Ishii M; Iida M; Seino Y
Gan To Kagaku Ryoho; 1994 Dec; 21(16):2779-86. PubMed ID: 7993114
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of tumor-associated antigen of the digestive tract by monoclonal antibody].
Imai K; Hinoda Y; Yachi A
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):2185-90. PubMed ID: 3606145
[TBL] [Abstract][Full Text] [Related]
16. [Clinical evaluation on an enzyme immunoassay kit for basic fetoprotein (BFP). (1) Clinical usefulness of BFP].
Ishii M; Hattori N; Kato T; Mochizuki M; Kamidono S; Sawabu N; Kawada Y; Kawai T; Abe O; Ohkura H
Gan To Kagaku Ryoho; 1988 Jul; 15(7):2107-13. PubMed ID: 2456039
[TBL] [Abstract][Full Text] [Related]
17. [Clinical study of the NCC-ST-439 EIA kit using serum from patients with various types of cancer and benign disease (1)].
Ohkura H; Hattori N; Miyazaki I; Sawabu N; Tobe R; Kawai K; Abe O; Ishii M; Kawai T; Kamano T
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1901-6. PubMed ID: 2439020
[TBL] [Abstract][Full Text] [Related]
18. Distribution of lung adenocarcinoma-associated antigens in human tissues and sera defined by monoclonal antibodies KM-52 and KM-93.
Shitara K; Hanai N; Yoshida H
Cancer Res; 1987 Mar; 47(5):1267-72. PubMed ID: 3545444
[TBL] [Abstract][Full Text] [Related]
19. [CA 15-3 is present as a novel tumor marker in the sera of patients with breast cancer and other malignancies].
Gang Y; Adachi I; Ohkura H; Yamamoto H; Mizuguchi Y; Abe K
Gan To Kagaku Ryoho; 1985 Dec; 12(12):2379-86. PubMed ID: 3865634
[TBL] [Abstract][Full Text] [Related]
20. [Tumor markers of pancreatic cancer].
Takami H; Hishinuma S; Shintoku J; Furuuchi T; Ogata Y; Abe O
Gan To Kagaku Ryoho; 1985 Feb; 12(2):212-9. PubMed ID: 3855615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]